ArticleCancers2025

A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.

Jessica Boklan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.